PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

November 4, 2011 (Tayside, Scotland) — With growing excitement over the emergence of transcatheter aortic-valve implantation (TAVI), might there still be room for an even less invasive option in ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

WASHINGTON, DC—There’s fresh evidence that off-label use of TAVR devices for pure native aortic valve regurgitation (NAVR) is associated with “not optimal” outcomes, although newer-generation devices, ...

PARIS -- Transcatheter aortic valve replacement (TAVR) with an updated version of the JenaValve appeared feasible in patients with severe aortic regurgitation who were at high surgical risk, according ...

A large study revealed that severe valvular heart disease is common among cancer patients and is associated with poorer ...

However, aortic regurgitation (AR) remains an "off-label" indication for TAVR, particularly for patients with mild or absent leaflet calcification or aortic annulus dimensions beyond the size of the ...

Routine echocardiography in cancer centers can spot severe valve disease earlier and trigger timely treatment decisions.

Aortic insufficiency is a potentially severe condition that affects the heart’s ability to pump blood. There are many possible causes for this condition. Aortic insufficiency is a form of heart valve ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

What is responsible for the myriad physical examination findings in patients with severe aortic regurgitation, including pulsation of multiple organs? When will the murmur of aortic valve ...